RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database
Identifiers
Identifiers
Date issued
2015Journal title
Modern Rheumatology
Type of content
Artigo